Cell Microsystems Announces First Commercial Sale of Automated AIR™ System for Single Cell Imaging, Sorting and Isolation

August 22, 2018 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today the first commercial sale of its automated AIR™ System for the imaging, sorting and isolation of single cells and small colonies. Albert Einstein College of Medicine investigator Jan... Read more

IsoPlexis Announces Expansion into Asia Pacific

IsoPlexis expands sales of its single-cell proteomic analysis platform, IsoLight and IsoCode Chip, to the pharmaceutical and life sciences markets in China BRANFORD, Conn., Aug. 20, 2018 /PRNewswire/ — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today an exclusive agreement with Tekon Biotech, a leading instrumentation distributor, to... Read more

Sphere Fluidics Appoints Dr Tris Vaughan (Vice President R&D Antibody Discovery and Protein Engineering for MedImmune) to their Scientific Advisory Board.

August 13, 2018 02:09 AM Pacific Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development... Read more

Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting

PDF Version Leading translational and clinical researchers to share new insights and best practices using Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced it will hold its 2nd Annual Imaging Mass Cytometry User Group Meeting September 10–11 at the Seattle Art Museum. In this... Read more

System enhancements provide laboratories with gold-standard1 accuracy to optimize patient care and reduce the risk of emerging antimicrobial resistance

BREA, CALIF. — (Aug. 1, 2018) — Beckman Coulter announced today commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology laboratories. The DxM MicroScan WalkAway system uses direct minimum inhibitory concentrations (MIC) for detection of antimicrobial resistance, offering greater confidence in results through gold-standard accuracy and the... Read more

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam

FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy CHICAGO – AACC – (July 31, 2018) – The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates. Delafloxacin is available for testing select fastidious and non-fastidious Gram positive and... Read more

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

PLEASANTON, CA.—July 31, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partners providing products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of... Read more

IsoPlexis Places IsoLight Single-Cell Proteomic Detection Instrument at Fred Hutchinson Cancer Research Center

The IsoLight is a first-of-its-kind system for high-throughput, single-cell functional proteomic detection BRANFORD, Conn., July 24, 2018 /PRNewswire/ — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, has installed its ground-breaking IsoLight benchtop system at Fred Hutchinson Cancer Research Center, as part of the company’s Early Adopter Program. The sample-to-answer... Read more

Takara Bio strengthens its IP position on single cell RNA-seq

MOUNTAIN VIEW, Calif., July 18, 2018 /PRNewswire/ — Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that patent JP6336080B—covering the Smart-seq2 method, developed by Rickard Sandberg and exclusively licensed to TBUSA by the Ludwig Institute—has been awarded by the Japan Patent Office. Additional patents regarding the Smart-seq2 technology... Read more